Alignment Healthcare (NASDAQ:ALHC) Reaches New 12-Month High - Still a Buy?

Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) hit a new 52-week high during trading on Friday . The stock traded as high as $15.05 and last traded at $14.97, with a volume of 2057610 shares trading hands. The stock had previously closed at $14.57.

Wall Street Analysts Forecast Growth

ALHC has been the subject of several analyst reports. KeyCorp initiated coverage on Alignment Healthcare in a research report on Friday, October 11th. They set a "sector weight" rating for the company. Stephens restated an "overweight" rating and issued a $17.00 price objective on shares of Alignment Healthcare in a report on Thursday, January 2nd. UBS Group increased their price objective on shares of Alignment Healthcare from $9.00 to $12.00 and gave the company a "neutral" rating in a report on Wednesday, October 30th. Stifel Nicolaus increased their target price on shares of Alignment Healthcare from $14.00 to $16.00 and gave the stock a "buy" rating in a report on Tuesday, January 14th. Finally, Barclays increased their target price on shares of Alignment Healthcare from $7.00 to $8.00 and gave the stock an "underweight" rating in a report on Wednesday, October 30th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, Alignment Healthcare has a consensus rating of "Moderate Buy" and an average target price of $11.88.

Alignment Healthcare Trading Up 2.7 %

The company has a debt-to-equity ratio of 1.82, a current ratio of 1.60 and a quick ratio of 1.60. The firm has a market capitalization of $2.87 billion, a P/E ratio of -19.44 and a beta of 1.45. The stock's 50-day simple moving average is $12.06 and its two-hundred day simple moving average is $10.94.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last announced its quarterly earnings results on Tuesday, October 29th. The company reported ($0.14) earnings per share for the quarter, hitting the consensus estimate of ($0.14). The company had revenue of $692.43 million for the quarter, compared to analysts' expectations of $662.11 million. Alignment Healthcare had a negative net margin of 5.84% and a negative return on equity of 108.69%. Alignment Healthcare's quarterly revenue was up 51.6% on a year-over-year basis. During the same quarter in the previous year, the business posted ($0.19) earnings per share. Equities research analysts expect that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Insider Buying and Selling

In other news, Director Joseph S. Konowiecki sold 6,920 shares of the company's stock in a transaction on Monday, November 11th. The shares were sold at an average price of $13.73, for a total transaction of $95,011.60. Following the completion of the sale, the director now owns 1,134,888 shares of the company's stock, valued at $15,582,012.24. This represents a 0.61 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Hakan Kardes sold 10,500 shares of the business's stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $14.99, for a total transaction of $157,395.00. Following the transaction, the insider now directly owns 309,944 shares in the company, valued at approximately $4,646,060.56. The trade was a 3.28 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 549,724 shares of company stock worth $6,965,685 in the last three months. Corporate insiders own 6.60% of the company's stock.

Hedge Funds Weigh In On Alignment Healthcare

A number of institutional investors and hedge funds have recently modified their holdings of ALHC. R Squared Ltd acquired a new stake in shares of Alignment Healthcare during the fourth quarter worth $55,000. SG Americas Securities LLC raised its holdings in shares of Alignment Healthcare by 11.7% in the fourth quarter. SG Americas Securities LLC now owns 49,272 shares of the company's stock worth $554,000 after acquiring an additional 5,163 shares during the last quarter. Ballentine Partners LLC acquired a new stake in shares of Alignment Healthcare during the 4th quarter worth about $121,000. JPMorgan Chase & Co. grew its stake in Alignment Healthcare by 249.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 288,219 shares of the company's stock worth $3,407,000 after acquiring an additional 205,705 shares during the period. Finally, Principal Financial Group Inc. increased its stake in shares of Alignment Healthcare by 1,335.1% during the 3rd quarter. Principal Financial Group Inc. now owns 194,043 shares of the company's stock valued at $2,294,000 after acquiring an additional 180,522 shares during the last quarter. Institutional investors and hedge funds own 86.19% of the company's stock.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.